Results 21 to 30 of about 11,725 (285)
CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids [PDF]
ABSTRACTA lipid nanoparticle (LNP) formulation is a state-of-the-art delivery system for genetic drugs such as DNA, mRNA, and siRNA, which is successfully applied to COVID-19 vaccines and gains tremendous interest in therapeutic applications. Despite its importance, a molecular-level understanding of the LNP structures and dynamics is still lacking ...
Soohyung Park +4 more
openaire +3 more sources
Ionizable lipid nanoparticles for in utero mRNA delivery [PDF]
Lipid nanoparticles deliver mRNA to mouse fetuses, which may ultimately enable in utero therapy to treat fetal genetic diseases.
Rachel S. Riley +12 more
openaire +3 more sources
Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery. [PDF]
Lipid nanoparticles (LNPs) have emerged as an effective and promising technology for messenger RNA (mRNA) delivery, offering a potential solution to physiological barriers and providing an alternative approach to gene therapy without the drawbacks associated with viral delivery.
Isaac I +5 more
europepmc +3 more sources
Development of a Library of Disulfide Bond-Containing Cationic Lipids for mRNA Delivery
Lipid nanoparticles (LNPs) are the commonly used delivery tools for messenger RNA (mRNA) therapy and play an indispensable role in the success of COVID-19 mRNA vaccines. Ionizable cationic lipids are the most important component in LNPs.
Zhigao Shen +8 more
doaj +1 more source
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
Lipid nanoparticles (LNPs) have recently emerged as one of the most advanced technologies for the highly efficient in vivo delivery of exogenous mRNA, particularly for COVID-19 vaccine delivery.
K. Swetha +7 more
doaj +1 more source
Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach [PDF]
Lipid nanoparticles (LNPs) containing short-interfering RNA (LNP-siRNA systems) are a promising approach for silencing disease-causing genes in hepatocytes following intravenous administration. LNP-siRNA systems are generated by rapid mixing of lipids in ethanol with siRNA in aqueous buffer (pH 4.0) where the ionizable lipid is positively charged ...
Takeshi Terada +6 more
openaire +3 more sources
Lipid Nanoparticles (LNPs) are a leading class of mRNA delivery systems. LNPs are made of an ionizable lipid, a polyethyleneglycol (PEG)-lipid conjugate and helper lipids.
Ayoub Medjmedj +5 more
doaj +1 more source
mRNA Synthesis and Encapsulation in Ionizable Lipid Nanoparticles
AbstractmRNA vaccines have recently generated significant interest due to their success during the COVID‐19 pandemic. Their success is due to advances in mRNA design and encapsulation into ionizable lipid nanoparticles (iLNPs). This has highlighted the potential for the use of mRNA‐iLNPs in other settings such as cancer, gene therapy, or vaccines for ...
McKenzie, Rebecca Elizabeth +4 more
openaire +2 more sources
New ionizable lipids reduce the lipid-to-mRNA ratio for base editing. [PDF]
Gao S, Xu Q.
europepmc +3 more sources
Lipid nanoparticles with ionizable lipids: Statistical aspects
Lipid nanoparticles (LNPs) with size ∼100 nm are now used for fabrication of a new generation of drugs and antiviral vaccines. To optimize their function or, more specifically, interaction with cell membranes, their composition often includes ionizable lipids which are neutral or cationic (after association with H^{+}).
openaire +2 more sources

